Germinated and Nongerminated Conidial Suspensions for Testing of Susceptibilities of Aspergillus spp. to Amphotericin B, Itraconazole, Posaconazole, Ravuconazole, and Voriconazole
暂无分享,去创建一个
[1] M. Ghannoum,et al. Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents , 2000, Journal of Clinical Microbiology.
[2] S. Sanche,et al. In Vitro Amphotericin B Resistance in Clinical Isolates of Aspergillus terreus, with a Head-to-Head Comparison to Voriconazole , 1999, Journal of Clinical Microbiology.
[3] B. D. de Pauw,et al. Invasive Aspergillosis Caused by Aspergillus ustus: Case Report and Review , 1999, Journal of Clinical Microbiology.
[4] E. Manavathu,et al. Comparative Study of Susceptibilities of Germinated and Ungerminated Conidia of Aspergillus fumigatus to Various Antifungal Agents , 1999, Journal of Clinical Microbiology.
[5] E. Johnson,et al. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. , 1998, The Journal of antimicrobial chemotherapy.
[6] A. Espinel-Ingroff. Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts , 1998, Journal of Clinical Microbiology.
[7] M. Ghannoum,et al. Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models , 1998, Antimicrobial Agents and Chemotherapy.
[8] D. Bonner,et al. In Vitro Activity of a New Oral Triazole, BMS-207147 (ER-30346) , 1998, Antimicrobial Agents and Chemotherapy.
[9] J. Guarro,et al. Comparison of in vitro antifungal susceptibilities of conidia and hyphae of filamentous fungi , 1997, Antimicrobial agents and chemotherapy.
[10] D. Denning,et al. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp , 1997, Antimicrobial agents and chemotherapy.
[11] J. Rex,et al. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi , 1997, Journal of clinical microbiology.
[12] S. Bhakdi,et al. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay , 1995, Journal of clinical microbiology.
[13] E. Anaissie,et al. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi , 1995, Antimicrobial agents and chemotherapy.
[14] J. Perfect,et al. NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. , 1994, The American journal of medicine.
[15] T. Gasser,et al. In Vitro Studies , 1992 .
[16] A. Espinel-Ingroff,et al. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi , 1991, Journal of clinical microbiology.
[17] B. Dupont,et al. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results. , 1987, Reviews of infectious diseases.
[18] V. Bezjak. Standardization of a hyphal inoculum of aspergilli for amphotericin B susceptibility testing , 1985, Journal of clinical microbiology.
[19] T. Granade,et al. Antimycotic susceptibility testing of dermatophytes in microcultures with a standardized fragmented mycelial inoculum , 1980, Antimicrobial Agents and Chemotherapy.
[20] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[21] G. Medoff,et al. Antimicrobial Susceptibility Testing of Six Clinical Isolates of Aspergillus , 1976, Antimicrobial Agents and Chemotherapy.
[22] J. Warr,et al. Resistance to various inhibitors in Aspergillus nidulans. , 1965, Journal of general microbiology.
[23] R. Donovick,et al. Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies. , 1955, Antibiotics annual.